BACKGROUND: Axis I comorbidity complicates diagnosing axis II personality disorders (PDs). PDs might influence Axis I outcome. No research has examined psychotherapy effects on PDs of treating Axis I comorbidity. Secondary analysis of a randomized controlled trial examined PD diagnostic stability after brief psychotherapy of chronic posttraumatic stress disorder (PTSD). METHODS:Patients with chronic PTSD were randomly assigned to 14 weeks of prolonged exposure, interpersonal psychotherapy, or relaxation therapy. Assessments included the Structured Clinical Interview for DSM-IV, Patient Version (SCID-P) and Structured Clinical Interview for DSM-IV Axis II Disorders (SCID-II) at baseline, week 14, and for treatment responders (≥30% clinician-administered PTSD scale improvement, defined a priori) at week 26 follow-up. We hypothesized patients whose PTSD improved would retain fewer baseline PD diagnoses posttreatment, particularly with personality traits PTSD mimics, e.g. paranoid and avoidant. RESULTS: Forty-seven (47%) of 99 SCID-II patients evaluated at baseline received a SCID-II diagnosis: paranoid (28%), obsessive-compulsive (27%), and avoidant (23%) PDs were most prevalent. Among 78 patients who repeated SCID-II evaluations posttreatment, 45% (N = 35) hadbaseline PD diagnoses, of which 43% (N = 15/35) lost at week 14. Three (7%) patients without baseline PDs acquired diagnoses at week 14; 10 others shifted diagnoses. Treatment modality and PTSD response were unrelated to PD improvement. Of treatment responders reevaluated at follow-up (N = 44), 56% with any baseline Axis II diagnosis had none at week 26. CONCLUSION: This first evaluation of Axis I psychotherapy effects on personality disorder stability found that acutely treating a chronic state decreased apparent trait-across most PDs observed. These exploratory findings suggest personality diagnoses may have limited prognostic meaning in treating chronic PTSD.
RCT Entities:
BACKGROUND: Axis I comorbidity complicates diagnosing axis II personality disorders (PDs). PDs might influence Axis I outcome. No research has examined psychotherapy effects on PDs of treating Axis I comorbidity. Secondary analysis of a randomized controlled trial examined PD diagnostic stability after brief psychotherapy of chronic posttraumatic stress disorder (PTSD). METHODS:Patients with chronic PTSD were randomly assigned to 14 weeks of prolonged exposure, interpersonal psychotherapy, or relaxation therapy. Assessments included the Structured Clinical Interview for DSM-IV, Patient Version (SCID-P) and Structured Clinical Interview for DSM-IV Axis II Disorders (SCID-II) at baseline, week 14, and for treatment responders (≥30% clinician-administered PTSD scale improvement, defined a priori) at week 26 follow-up. We hypothesized patients whose PTSD improved would retain fewer baseline PD diagnoses posttreatment, particularly with personality traits PTSD mimics, e.g. paranoid and avoidant. RESULTS: Forty-seven (47%) of 99 SCID-IIpatients evaluated at baseline received a SCID-II diagnosis: paranoid (28%), obsessive-compulsive (27%), and avoidant (23%) PDs were most prevalent. Among 78 patients who repeated SCID-II evaluations posttreatment, 45% (N = 35) had baseline PD diagnoses, of which 43% (N = 15/35) lost at week 14. Three (7%) patients without baseline PDs acquired diagnoses at week 14; 10 others shifted diagnoses. Treatment modality and PTSD response were unrelated to PD improvement. Of treatment responders reevaluated at follow-up (N = 44), 56% with any baseline Axis II diagnosis had none at week 26. CONCLUSION: This first evaluation of Axis I psychotherapy effects on personality disorder stability found that acutely treating a chronic state decreased apparent trait-across most PDs observed. These exploratory findings suggest personality diagnoses may have limited prognostic meaning in treating chronic PTSD.
Authors: Mary C Zanarini; Frances R Frankenburg; John Hennen; D Bradford Reich; Kenneth R Silk Journal: Am J Psychiatry Date: 2004-11 Impact factor: 18.112
Authors: J M Oldham; A E Skodol; H D Kellman; S E Hyler; N Doidge; L Rosnick; P E Gallaher Journal: Am J Psychiatry Date: 1995-04 Impact factor: 18.112
Authors: John G Gunderson; Robert L Stout; M Tracie Shea; Carlos M Grilo; John C Markowitz; Leslie C Morey; Charles Sanislow; Shirley Yen; Mary C Zanarini; Alex S Keuroghlian; Thomas H McGlashan; Andrew E Skodol Journal: J Clin Psychiatry Date: 2014-08 Impact factor: 4.384
Authors: John R Keefe; Barbara L Milrod; Robert Gallop; Jacques P Barber; Dianne L Chambless Journal: Depress Anxiety Date: 2017-12-06 Impact factor: 6.505
Authors: Inga Aarts; Chris Vriend; Aishah Snoek; Arne van den End; Matthijs Blankers; Aartjan T F Beekman; Jack Dekker; Odile A van den Heuvel; Kathleen Thomaes Journal: Borderline Personal Disord Emot Dysregul Date: 2021-05-05
Authors: Arne van den End; Jack Dekker; Aartjan T F Beekman; Inga Aarts; Aishah Snoek; Matthijs Blankers; Chris Vriend; Odile A van den Heuvel; Kathleen Thomaes Journal: Front Psychiatry Date: 2021-03-19 Impact factor: 4.157
Authors: Barbara Milrod; John R Keefe; Tse-Hwei Choo; Shay Arnon; Sara Such; Ari Lowell; Yuval Neria; John C Markowitz Journal: Depress Anxiety Date: 2020-02-25 Impact factor: 6.505